References

Alessi, S.M.; Hanson, T.; Wieners, M.; and Petry, N.M. Low-cost contingency management in community clinics: Delivering incentives partially in group therapy. Experimental and Clinical Psychopharmacology 15(3):293-300, 2007.

Bannon, M.; Kapatos, G.; and Albertson, D. Gene expression profiling in the brains of human cocaine abusers. Addict Biol 10(1):119-126, 2005.

Des Jarlais, D.C., et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 21(2):231-235, 2007.

Farrer, L.A., et al. Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry 66(3):267-274, 2009.

Gold, M.S. Cocaine (and crack): Clinical aspects. In: Lowinson, J.H., ed. Substance Abuse: A Comprehensive Textbook, 3rd edition, Baltimore: Williams & Wilkins, pp. 181-198, 1997.

Hagan, H., et al. HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy 18:341-351, 2007.

Institute for Social Research. Monitoring the Future, 2008 (Study Results). Ann Arbor, MI: University of Michigan, 2008. Data retrieved 12/11/2008 from http://www.monitoringthefuture.org.

Martell, B.A., et al. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biological Psychiatry 58(2):158-164, 2005.

Shoptaw, S., et al. Randomized placebo-controlled trial of baclofen for cocaine dependence: Preliminary effects for individuals with chronic patterns of cocaine use. Journal of Clinical Psychiatry 64(12):1440-1448, 2003.

Snyder, S.H. Drugs and the Brain. New York: Scientific American Library, 1996.

Sokoloff, P., et al. The dopamine D3 receptor: A therapeutic target for the treatment of neuropsychiatric disorders. CNS and Neurological Disorders -Drug Targets 5(1):25-43, 2006. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings. DHHS Pub. No. SMA 08-4343, Rockville, MD: SAMHSA, 2008.

Suh, J.J.; Pettinati, H.M.; Kampman, K.M.; and O'Brien, C.P. The status of disulfiram: A half of a century later. Journal of Clinical Psychopharmacology 26(3):290-302, 2006.

Teich-Alasia, S. Burn care facilities in Italy. Burns 18(2):139-140, 1992.

Tseng, F.-C., et al. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology 46(3):666-671, 2007.

Volkow, N.D., et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386(6627):830-833, 1997.

Zhang, H., et al. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: Evidence and replications across family- and population-based studies. Biol Psychiatry. 2009 Feb 12; [Epub ahead of print].

Zuo, L., et al. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: A replication study in family-based sample and population-based sample. Neuropsychopharmacology. 2008 Dec 3; [Epub before print].